Skip to content


Harry Cassin
Publisher and Editor

Andy Spalding
Senior Editor

Jessica Tillipman
Senior Editor

Bill Steinman
Senior Editor

Richard L. Cassin
Editor at Large

Elizabeth K. Spahn
Editor Emeritus

Cody Worthington
Contributing Editor

Julie DiMauro
Contributing Editor

Thomas Fox
Contributing Editor

Marc Alain Bohn
Contributing Editor

Bill Waite
Contributing Editor

Russell A. Stamets
Contributing Editor

Richard Bistrong
Contributing Editor

Eric Carlson
Contributing Editor

SFO launches criminal probe of GSK

GlaxoSmith Kline PLC is under investigation by the UK Serious Fraud Office for possible criminal violations, the pharma said Tuesday.

In a two-sentence statement, UK-based GSK said it had been informed by the SFO of a formal criminal investigation into GSK’s commercial practices.

GSK said it was committed to operating its business to the highest ethical standards and will continue to cooperate fully with the SFO.

In July last year, China authorities accused GSK of paying $482 million in bribes to health officials and doctors to boost sales. China’s Ministry of Public Security said since 2007 GSK had used 700 travel agents to deliver the illegal payments since 2007. 

Earlier this month, a Ministry of Public Security official arrested Mark Reilly, the British former boss of GSK’s China unit, and two Chinese executives, Zhang Guowei and Zhao Hongyan, for offering bribes to hospital personnel and doctors.

All three defendants face up to life in prison.

Outside China, GSK opened an investigation into its sales practices in the Middle East.

In April, the company said it was investigating allegations that it had hired government-employed doctors and pharmacists in Iraq to serve as paid sales reps for its products.

GSK is also investigating alleged bribery of doctors in Jordan and Lebanon.

Polish authorities have also said they are investigating alleged bribery of doctors by GSK representatives.


Julie DiMauro is the executive editor of the FCPA Blog and can be reached here.

Share this post


Comments are closed for this article!